In esophageal adenocarcinoma, expression of IFITM1 had no impact on TTR and OS in the Kaplan-Meier-analyses (Fig. 3a, d), but in the adjusted Cox regression analyses (Table 3 and Additional file 1: Table S1)) high IFITM1 expression had a negative impact on both TTR (HR 3.05, 95 % CI 1.09-8.53, p = 0.034) and OS (HR 2.71, 95 % CI 1.11-6.67, p = 0.029). This evidence concerns the gene TTR and esophageal adenocarcinoma.